(IN BRIEF) Scientists at the Institute of Cancer Research, London, together with colleagues from TUD Dresden University of Technology, have discovered that oxidation of a single site in the protein p21 acts as a chemical switch determining whether cells keep … Read the full press release →
Posted in Business, Education, Financial, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged ageing, BIOTEC, cancer therapy, CDK2, cell cycle, cysteine 41, Institute of Cancer Research, Jörg Mansfeld, Julia Vorhauser, Molecular Cell, oxidative modification, p21, partnership, radiotherapy resistance, Reactive oxygen species, redox proteomics, senescence, TUD Dresden University of Technology